The EGF/ErbB receptor family and apoptosis

被引:94
|
作者
Danielsen, AJ [1 ]
Maihle, NJ [1 ]
机构
[1] Mayo Clin, Dept Biochem & Mol Biol, Tumor Biol Program, Rochester, MN 55905 USA
关键词
EGF; ErbB receptors; apoptosis; death signaling; survival signals; breast cancer;
D O I
10.1080/08977190290022185
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ErbB receptor family can activate a multitude of cell signaling pathways that involve many aspects of cellular function. The four members of the ErbB receptor family interact with diverse ligands and substrates, as well as with each other through cell surface heterodimerization. The sum of these diverse interactions is a signaling network that is complex but also finely regulated. Among the cellular functions influenced by ErbB signaling is cell survival. ErbB receptor signaling has been demonstrated to interact with all of the major mechanisms of cell death signaling in a manner that promotes cell survival. Survival factors such as Ras, PI3-K, Akt, and Bcl-x/-2 all have been shown to be activated by ErbB signaling (Fig. 5). ErbB abrogation of apoptotic signals has been shown to play an important role during embryonic tissue development, in normal adult tissue maintenance (e.g. mammary tissue, wound healing), and also in tumor development and progression. Although the majority of studies suggest that ErbB receptor family members are mediators of cell survival, there have been occasional reports suggesting that ErbB receptors can induce cell death under selected experimental conditions. While this apparent discrepancy remains unresolved, in many of these reports, cell death may be the result of anoikis in response to changes in the cytoskeleton associated with hyperstimulation of ErbB signaling. The notion that ErbB receptor family members function to promote cell survival is not a recent observation. However, how this family functions to prevent apoptosis is an area that only recently has been considered. The understanding of ErbB receptor signaling as it relates to the avoidance of apoptosis had profound implications for the treatment of solid tumors originating in multiple tissues, as well as for the treatment of neurodegenerative disease. Further elucidation of the complex relationships between ErbB receptor signaling networks and the apoptotic machinery is certain to yield biologically important and potentially life-saving information.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] REGIONAL MAPPING OF THE EGF RECEPTOR (EGFR)/C-ERBB PROTOONCOGENE
    SHIMIZU, N
    HUNTS, J
    MERLINO, G
    WANGPENG, J
    XU, YH
    YAMAMOTO, T
    TOYOSHIMA, K
    PASTAN, I
    CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4): : 743 - 744
  • [22] Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3
    Chen, XM
    Yeung, TK
    Wang, ZX
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (03) : 757 - 763
  • [23] Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells
    Kornblum, HI
    Yanni, DS
    Easterday, MC
    Seroogy, KB
    DEVELOPMENTAL NEUROSCIENCE, 2000, 22 (1-2) : 16 - 24
  • [24] The ErbB receptor family: a therapeutic target for cancer
    de Bono, JS
    Rowinsky, EK
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S19 - S26
  • [25] Evolution and functional divergence of the ERBB receptor family
    Wu, Shanshan
    Haltom, Jeffrey
    Zhao, Wenyi
    Yang, Jingwen
    Zhou, Zhan
    Gu, Xun
    PHARMACOGENOMICS, 2021, 22 (08) : 473 - 484
  • [26] The EGF receptor family as targets for cancer therapy
    Mendelsohn, J
    Baselga, J
    ONCOGENE, 2000, 19 (56) : 6550 - 6565
  • [27] Mechanisms of Autoinhibition and Dimerization of the EGF Receptor Family
    Byrne, Patrick
    Hristova, Kalina
    Leahy, Daniel
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 351A - 351A
  • [28] The ErbB receptor tyrosine family as signal integrators
    Hynes, NE
    Horsch, K
    Olayioye, MA
    Badache, A
    ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 151 - 159
  • [29] Evolutionary analysis of the erbB receptor and ligand family
    Stein, RA
    Staros, JV
    FASEB JOURNAL, 1999, 13 (07): : A1468 - A1468
  • [30] The EGF receptor family as targets for cancer therapy
    John Mendelsohn
    Jose Baselga
    Oncogene, 2000, 19 : 6550 - 6565